Osteonecrosis Linked to Corticosteroid Use in SLE

August 14, 2018

This complication occurs in up to 44% of patients with systemic lupus erythematosus.

Reference1. Hussein S, Suitner M, BÃ©land-Bonenfant S, et al. Monitoring of osteonecrosis in systemic lupus erythematosus patients: a systematic review and metaanalysis. J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi:10.3899/jrheum.170837. [Epub ahead of print]

Hussein and colleagues in Canada have discovered a potentially strong association between corticosteroid use in systemic lupus erythematosus (SLE) and osteonecrosis.¹ Scroll through the slides for the details of the study and the take-home points for physicians.

(Image credit: ©ImagePointFr/Shutterstock.com)

SLE, systemic lupus erythematosus.

Note that osteonecrosis was not associated with any other drug nor with any specific laboratory finding.

Related Content:

Osteonecrosis Linked to Corticosteroid Use in SLE

Gregory M. Weiss, MD